A University of Colorado professor who experienced a funding freeze firsthand this year expressed relief at the program's preservation.

Kenya is set to roll out the long-acting injectable HIV Pre-Exposure prophylaxis (PrEP) Lenacapavir by January 2026 following ...

Popular global HIV/AIDS program PEPFAR has been spared as Congress passes a package with billions of dollars in spending cuts ...

Kenya has been picked among nine countries for the trials of the new injectable HIV prevention drug that has been rolled out ...

Kenya is set to introduce a revolutionary injectable HIV prevention drug, Lenacapavir, becoming one of nine African nations ...

Kenya has been selected as one of the 9 early adopter countries for the rollout of Lenacapavir (LEN), a long-acting ...

The Global Fund has announced that it signed an access agreement with Gilead Sciences to procure lenacapavir, a twice-a-year injection that has a 99 per cent success rate in preventing HIV ...

Countries like Kenya are redoubling their efforts to meet ambitious global goals to eliminate pediatric HIV/AIDS. As they develop plans for continuity of care in future health crises, hearing directly ...

Benta and Daniel live near Lake Victoria in Kenya, a region that has one of the highest HIV rates in the country. More than 1 in 6 people are infected with the virus. Sponsor Message ...

On Thursday, about 200 people living with HIV in Kisumu, Kenya’s third largest city, held a peaceful protest wearing T-shirts reading “My ARV’s My Life” and carrying posters that read “A ...

Kenya has the seventh-largest number of people living with HIV in the world, at around 1.4 million, according to World Health Organization data.